G Trademark

Trademark Overview


On Thursday, October 26, 2023, a trademark application was filed for G with the United States Patent and Trademark Office. The USPTO has given the G trademark a serial number of 98241046. The federal status of this trademark filing is REGISTERED as of Tuesday, November 12, 2024. This trademark is owned by Galapagos NV. The G trademark is filed in the Pharmaceutical Products, Computer & Software Services & Scientific Services, and Medical & Beauty Services & Agricultural Services categories with the following description:

Pharmaceutical substances and preparations for human use for the treatment of bone cartilage and joint disease, autoinflammation diseases, autoimmune diseases, proliferative diseases, endocrine diseases, metabolic diseases, skin diseases, lung diseases, fibrotic diseases, cardiovascular diseases, pain, hepatitis B virus, kidney diseases, osteoporosis, osteoarthritis, rheumatoid arthritis, atopic dermatitis, idiopathic pulmonary fibrosis, inflammatory bowel disease, Crohn's disease, ulcerative colitis, ankylosing spondylitis, psoriatic arthritis, Sjogren's syndrome, lupus, uveitis, scleroderma, non-alcoholic steatohepatitis, polycystic kidney disease, type 2 diabetes; Biopharmaceutical substances and preparations for human use for the treatment of bone cartilage and joint disease, autoinflammation diseases, autoimmune diseases, proliferative diseases, endocrine diseases, metabolic diseases, skin diseases, lung diseases, fibrotic diseases, cardiovascular diseases, pain, hepatitis B virus...

Medical services; providing medical and pharmaceutical advice; gene bank services

Medical, scientific and industrial research services; industrial research in the field of pharmaceuticals; pharmaceutical and biopharmaceutical research and development services; scientific and medical research services in the nature of examining and testing of genes; pharmaceutical and biopharmaceutical drug development services featuring the examination and testing of pharmaceutical and biopharmaceutical semi-finished products for use in medicaments; pharmaceutical drug development services featuring the examination and testing of medicaments; product research and development in the field of test systems for pharmaceutical and biopharmaceutical products; database development services , namely configuration and customization of computer databases containing information regarding medical, pharmaceutical and biopharmaceutical information; Pharmaceutical drug development services
g

General Information


Serial Number98241046
Word MarkG
Filing DateThursday, October 26, 2023
Status700 - REGISTERED
Status DateTuesday, November 12, 2024
Registration Number7562966
Registration DateTuesday, November 12, 2024
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, August 27, 2024

Trademark Statements


Description of MarkThe mark consists of the letter "G" in white superimposed on a square field filled with the gradient composed of orange, teal, and turquoise.
Goods and ServicesPharmaceutical substances and preparations for human use for the treatment of bone cartilage and joint disease, autoinflammation diseases, autoimmune diseases, proliferative diseases, endocrine diseases, metabolic diseases, skin diseases, lung diseases, fibrotic diseases, cardiovascular diseases, pain, hepatitis B virus, kidney diseases, osteoporosis, osteoarthritis, rheumatoid arthritis, atopic dermatitis, idiopathic pulmonary fibrosis, inflammatory bowel disease, Crohn's disease, ulcerative colitis, ankylosing spondylitis, psoriatic arthritis, Sjogren's syndrome, lupus, uveitis, scleroderma, non-alcoholic steatohepatitis, polycystic kidney disease, type 2 diabetes; Biopharmaceutical substances and preparations for human use for the treatment of bone cartilage and joint disease, autoinflammation diseases, autoimmune diseases, proliferative diseases, endocrine diseases, metabolic diseases, skin diseases, lung diseases, fibrotic diseases, cardiovascular diseases, pain, hepatitis B virus, kidney diseases, osteoporosis, osteoarthritis, rheumatoid arthritis, atopic dermatitis, idiopathic pulmonary fibrosis, inflammatory bowel disease, Crohn's disease, ulcerative colitis, ankylosing spondylitis, psoriatic arthritis, Sjogren's syndrome, lupus, uveitis, scleroderma, non-alcoholic steatohepatitis, polycystic kidney disease, type 2 diabetes
Pseudo MarkGALAPAGOS
Indication of Colors claimedThe color(s) white, orange, teal, and turquoise is/are claimed as a feature of the mark.
Goods and ServicesMedical services; providing medical and pharmaceutical advice; gene bank services
Goods and ServicesMedical, scientific and industrial research services; industrial research in the field of pharmaceuticals; pharmaceutical and biopharmaceutical research and development services; scientific and medical research services in the nature of examining and testing of genes; pharmaceutical and biopharmaceutical drug development services featuring the examination and testing of pharmaceutical and biopharmaceutical semi-finished products for use in medicaments; pharmaceutical drug development services featuring the examination and testing of medicaments; product research and development in the field of test systems for pharmaceutical and biopharmaceutical products; database development services , namely configuration and customization of computer databases containing information regarding medical, pharmaceutical and biopharmaceutical information; Pharmaceutical drug development services

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, November 1, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, November 1, 2023
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, November 1, 2023
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameGalapagos NV
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressMechelen 2800
BE

Party NameGalapagos NV
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressMechelen 2800
BE

Party NameGalapagos NV
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressMechelen 2800
BE

Trademark Events


Event DateEvent Description
Monday, October 30, 2023NEW APPLICATION ENTERED
Wednesday, November 1, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, November 2, 2023NOTICE OF DESIGN SEARCH CODE E-MAILED
Sunday, June 9, 2024ASSIGNED TO EXAMINER
Thursday, June 13, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, July 22, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, July 22, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, July 22, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, July 23, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, August 7, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, August 27, 2024PUBLISHED FOR OPPOSITION
Tuesday, August 27, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 12, 2024REGISTERED-PRINCIPAL REGISTER
Tuesday, November 12, 2024NOTICE OF REGISTRATION CONFIRMATION EMAILED
Thursday, June 13, 2024NON-FINAL ACTION E-MAILED
Thursday, June 13, 2024NON-FINAL ACTION WRITTEN